CDC-RFA-CE22-2202: E-Learning Collaborative for Sexual Violence and Intimate Partner Violence Prevention
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCIPC notices from 2021.
Centers for Disease Control - NCIPC offered grants of up to $345,000 (at least $300,000) to any type of organization. It expected to make one award worth $1.0 million in total. Applications closed on November 17, 2021.
From the official notice on Grants.gov, last changed October 29, 2021. Checked November 7, 2026.
- Award ceiling$345,000
- Award floor$300,000
- Total funding$1.0 million
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | September 14, 2021 |
|---|---|
| Deadline | November 17, 2021 |
| Archived by Grants.gov | December 17, 2021 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
N/A
Is this a realistic fit?
- Past Injury Prevention and Control Research and State and Community Based Programs awards averaged $2.2 million; this notice allows up to $345,000 per award.
- Most of the program's money (76% over five years) went to state and local governments.
- No cost sharing or match is required.
What the grant funds
Sexual violence (SV) and intimate partner violence (IPV) are preventable public health problems that have long-term physical and mental health impact on victims and affect millions of Americans. The purpose of this NOFO is to support an E-Learning community and peer learning platform that uses multiple communication channels, including interactive web conference series, podcasts, online education resources, translation products, and planed and strategic social media to build and strengthen violence prevention systems for the Division of Violence Prevention’s funded recipients, sub-recipients and prevention practitioners nationally. This will be accomplished by providing technical assistance, training, and information on how to utilize the best available evidence to select, implement, and evaluate efforts to decrease SV and IPV and to incorporate health equity into prevention efforts. The majority of the E-Learning Collaborative’s activities will be specifically tailored for CDC program recipients, though the broader national SV/IPV prevention field will also benefit from the efforts. The goal of this NOFO is to increase knowledge, skill, and capacity to implement strategies to prevent SV and IPV in communities at greatest risk.
Who has won Injury Prevention and Control Research and State and Community Based Programs grants before
From fiscal 2021 to 2025, Injury Prevention and Control Research and State and Community Based Programs (93.136) awarded $2.2 billion across 986 grant awards, an average of $2.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Florida Department of Health | Florida | 12 | $81.1 million |
| California Department of Public Health | California | 11 | $55.4 million |
| Ohio Department of Health | Ohio | 9 | $42.0 million |
| North Carolina Department of Health & Human Services | North Carolina | 12 | $42.0 million |
| Michigan Department of Health and Human Services | Michigan | 10 | $37.9 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-CE22-2202 still open?
No. It closed on November 17, 2021. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for E-Learning Collaborative for Sexual Violence and Intimate Partner Violence Prevention?
Centers for Disease Control - NCIPC accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for E-Learning Collaborative for Sexual Violence and Intimate Partner Violence Prevention?
Closed November 17, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $345,000 each. About $1.0 million in total for one award.
Who has won Injury Prevention and Control Research and State and Community Based Programs grants before?
The largest recipients over five fiscal years were Florida Department of Health, California Department of Public Health, Ohio Department of Health. The program made 986 awards worth $2.2 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)